Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The magnitude and nature of the decrease in coronary heart disease mortality rate.

M Feinleib

    The American Journal of Cardiology
    |August 27, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Mortality surveillance system: the first models from year.

    Vital and health statistics. Series 20, Data from the National Vital Statistics System·2014
    Same author

    Mortality surveillance system: models from the second year.

    Vital and health statistics. Series 20, Data from the National Vital Statistics System·2014
    Same author

    Association between endogenous sex steroid hormones and inflammatory biomarkers in US men.

    Andrology·2013
    Same author

    Brian MacMahon (1923-2007): founder of modern epidemiology.

    Cancer causes & control : CCC·2008
    Same author

    Folate fortification for the prevention of birth defects: case study.

    American journal of epidemiology·2001
    Same author

    Mortality of men versus women in comparable high-level jobs: 15-year experience in the Federal Women's Study.

    American journal of epidemiology·2001

    Cardiovascular disease mortality has significantly declined in the US, with rates dropping by 40% over 30 years. This trend, linked to improved prevention and treatment, has increased life expectancy across all demographics.

    Area of Science:

    • Public Health
    • Epidemiology
    • Cardiovascular Medicine

    Background:

    • Cardiovascular disease remains a leading cause of death in the United States.
    • Significant progress has been made in reducing age-adjusted cardiovascular mortality rates, particularly since the late 1960s.
    • The decline in cardiovascular disease mortality has contributed to increased life expectancy for all demographic groups.

    Purpose of the Study:

    • To analyze the trends and contributing factors in the decline of cardiovascular mortality in the United States.
    • To examine the impact of changes in incidence and case fatality on overall cardiovascular disease deaths.
    • To explore methods for estimating the effects of risk factor modification on cardiovascular disease outcomes.

    Main Methods:

    • Analysis of age-adjusted cardiovascular mortality rates over a 30-year period.

    Related Experiment Videos

  • Examination of changes in life expectancy across different racial and gender groups.
  • Review of factors influencing cardiovascular disease incidence and case fatality.

    • Main Results:

    • A 40% decrease in age-adjusted cardiovascular mortality rates in the US over the last 30 years.
    • An estimated 300,000 fewer deaths from coronary heart disease between 1968 and 1978 due to unchanged mortality rates.
    • Increased life expectancy between 1970 and 1980, with notable gains for black men and women.
    • Variations in mortality decline across different regions and demographic groups, with a significant impact on the black population.

    Conclusions:

    • The decline in cardiovascular mortality is a significant public health achievement, though cardiovascular disease remains a major concern.
    • Understanding changes in incidence and case fatality is crucial for analyzing mortality trends.
    • Further research into risk factor modification, including smoking, hypertension, and cholesterol, shows promising results for reducing cardiovascular disease burden.